Participation of CYP2A in cocaine-induced hepatotoxicity in female mice

Citation
K. Aoki et al., Participation of CYP2A in cocaine-induced hepatotoxicity in female mice, PHARM TOX, 87(1), 2000, pp. 26-32
Citations number
39
Categorie Soggetti
Pharmacology & Toxicology
Journal title
PHARMACOLOGY & TOXICOLOGY
ISSN journal
09019928 → ACNP
Volume
87
Issue
1
Year of publication
2000
Pages
26 - 32
Database
ISI
SICI code
0901-9928(200007)87:1<26:POCICH>2.0.ZU;2-4
Abstract
Female ICR mice were treated with cocaine either alone or in combination wi th one of several cytochrome P450 (CYP) inducers, i.e. phenobarbital, beta- ionone, dexamethasone and beta-naphthoflavone. Cocaine-induced hepatotoxici ty was first observed by pretreatment with phenobarbital, beta-ionone or de xamethasone in accordance with significant elevation of cocaine N-demethyla tion, the first step of cocaine bioactivation. The hepatic lesions occured in the periportal region (zone 1) by phenobarbital and beta-ionone and in t he perivenular region (zone 3) by dexamethasone. The activities of the enzy me specific for CW isozyme were determined to elucidate the effects of pret reatment with CYP inducers. beta-Naphthoflavone induced CYP1A and 2B but ha d no effects on hepatotoxicity by cocaine. On the other hand, beta-ionone e nhanced hepatotoxicity without induction of CYP3A. Activities of cocaine N- demethylase correlated well with CYP2A (r = 0.83) and CYP2B (r = 0.81). Coc aine N-demethylation was inhibited particularly by addition of the CYP2A sp ecific inhibitor, 8-methoxypsoralen. Moreover, pretreatment with 8-methoxyp soralen produced a marked inhibition of the hepatotoxicity induced by cocai ne in phenobarbital-treated mice. These results suggest that cocaine-induce d hepatotoxicity in female mice was mediated in part by CYP2A, participatin g in cocaine N-demethylation.